372 related articles for article (PubMed ID: 24211404)
1. Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis.
Zubiri I; Posada-Ayala M; Sanz-Maroto A; Calvo E; Martin-Lorenzo M; Gonzalez-Calero L; de la Cuesta F; Lopez JA; Fernandez-Fernandez B; Ortiz A; Vivanco F; Alvarez-Llamas G
J Proteomics; 2014 Jan; 96():92-102. PubMed ID: 24211404
[TBL] [Abstract][Full Text] [Related]
2. Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomes.
Zubiri I; Posada-Ayala M; Benito-Martin A; Maroto AS; Martin-Lorenzo M; Cannata-Ortiz P; de la Cuesta F; Gonzalez-Calero L; Barderas MG; Fernandez-Fernandez B; Ortiz A; Vivanco F; Alvarez-Llamas G
Transl Res; 2015 Nov; 166(5):474-484.e4. PubMed ID: 26072307
[TBL] [Abstract][Full Text] [Related]
3. Urinary exosomes and diabetic nephropathy: a proteomic approach.
Raimondo F; Corbetta S; Morosi L; Chinello C; Gianazza E; Castoldi G; Di Gioia C; Bombardi C; Stella A; Battaglia C; Bianchi C; Magni F; Pitto M
Mol Biosyst; 2013 Jun; 9(6):1139-46. PubMed ID: 23344851
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Non-Invasive Urinary Exosomal Biomarker for Diabetic Nephropathy Using Data-Independent Acquisition Proteomics.
Ding X; Zhang D; Ren Q; Hu Y; Wang J; Hao J; Wang H; Zhao X; Wang X; Song C; Du J; Yang F; Zhu H
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686366
[TBL] [Abstract][Full Text] [Related]
5. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R
PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277
[TBL] [Abstract][Full Text] [Related]
6. Potential urine biomarkers for the diagnosis of prediabetes and early diabetic nephropathy based on ISN CKHDP program.
Gu D; Chen Y; Masucci M; Xiong C; Zou H; Holthofer H
Clin Nephrol; 2020; 93(1):129-133. PubMed ID: 32145759
[TBL] [Abstract][Full Text] [Related]
7. Stage-specific quantitative changes in renal and urinary proteome during the progression and development of streptozotocin-induced diabetic nephropathy in rats.
Sharma V; Tikoo K
Mol Cell Biochem; 2014 Mar; 388(1-2):95-111. PubMed ID: 24281856
[TBL] [Abstract][Full Text] [Related]
8. Changes in urine proteome accompanying diabetic nephropathy progression.
Lewandowicz A; Bakun M; Kohutnicki R; Fabijańska A; Kistowski M; Imiela J; Dadlez M
Pol Arch Med Wewn; 2015; 125(1-2):27-38. PubMed ID: 25578432
[TBL] [Abstract][Full Text] [Related]
9. Urinary Proteome Analysis Identified Neprilysin and VCAM as Proteins Involved in Diabetic Nephropathy.
Guillén-Gómez E; Bardají-de-Quixano B; Ferrer S; Brotons C; Knepper MA; Carrascal M; Abian J; Mas JM; Calero F; Ballarín JA; Fernández-Llama P
J Diabetes Res; 2018; 2018():6165303. PubMed ID: 29854824
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Elf3 on Smad3 activation-dependent injuries in podocytes and excretion of urinary exosome in diabetic nephropathy.
Sakurai A; Ono H; Ochi A; Matsuura M; Yoshimoto S; Kishi S; Murakami T; Tominaga T; Nagai K; Abe H; Doi T
PLoS One; 2019; 14(5):e0216788. PubMed ID: 31150422
[TBL] [Abstract][Full Text] [Related]
11. Identification of nephropathy predictors in urine from children with a recent diagnosis of type 1 diabetes.
Magagnotti C; Zerbini G; Fermo I; Carletti RM; Bonfanti R; Vallone F; Andolfo A
J Proteomics; 2019 Feb; 193():205-216. PubMed ID: 30366120
[TBL] [Abstract][Full Text] [Related]
12. Urinary Exosomal mRNA of WT1 as Diagnostic and Prognostic Biomarker for Diabetic Nephropathy.
Abe H; Sakurai A; Ono H; Hayashi S; Yoshimoto S; Ochi A; Ueda S; Nishimura K; Shibata E; Tamaki M; Kishi F; Kishi S; Murakami T; Nagai K; Doi T
J Med Invest; 2018; 65(3.4):208-215. PubMed ID: 30282862
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of urine exosomes derived from rats with diabetic kidney disease.
Mishra DD; Sahoo B; Maurya PK; Sharma R; Varughese S; Prasad N; Tiwari S
Front Endocrinol (Lausanne); 2023; 14():1157194. PubMed ID: 37251672
[TBL] [Abstract][Full Text] [Related]
14. Wilm's tumor-1 protein levels in urinary exosomes from diabetic patients with or without proteinuria.
Kalani A; Mohan A; Godbole MM; Bhatia E; Gupta A; Sharma RK; Tiwari S
PLoS One; 2013; 8(3):e60177. PubMed ID: 23544132
[TBL] [Abstract][Full Text] [Related]
15. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
Eissa S; Matboli M; Bekhet MM
Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
[TBL] [Abstract][Full Text] [Related]
16. [Early detection by urinary proteome analysis : A new concept in patient management of diabetic nephropathy].
Beige J; Drube J; von der Leyen H; Pape L; Rupprecht H
Internist (Berl); 2020 Oct; 61(10):1094-1105. PubMed ID: 32897404
[TBL] [Abstract][Full Text] [Related]
17. A systematic review and Meta-analysis of urinary extracellular vesicles proteome in diabetic nephropathy.
Ding X; Wang X; Du J; Han Q; Zhang D; Zhu H
Front Endocrinol (Lausanne); 2022; 13():866252. PubMed ID: 36034457
[TBL] [Abstract][Full Text] [Related]
18. Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy.
Rossi L; Nicoletti MC; Carmosino M; Mastrofrancesco L; Di Franco A; Indrio F; Lella R; Laviola L; Giorgino F; Svelto M; Gesualdo L; Procino G
J Diabetes Res; 2017; 2017():4360357. PubMed ID: 28246612
[TBL] [Abstract][Full Text] [Related]
19. Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy.
Abdel Ghafar MT; Shalaby KH; Okda HI; Abo El Gheit RE; Soliman NA; Keshk WA
J Investig Med; 2020 Mar; 68(3):748-755. PubMed ID: 31722957
[TBL] [Abstract][Full Text] [Related]
20. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
